Scientists make critical insights into T-cell development

August 11, 2017, Monash University
Scientists make critical insights into T-cell development
Credit: Monash University

Mutations in the gene encoding the enzyme protein tyrosine phosphatase N2 (PTPN2) have been associated with the development of autoimmune disease including Type 1 diabetes, Crohn's Disease and rheumatoid arthritis.

In important fundamental research, Monash University researchers have identified a crucial part of the enzyme's role in early T-cell , and have shown that decreased levels of this enzyme can lead to the type of T-cells that can contribute to the development of autoimmune disease.

Autoimmune diseases represent a broad spectrum of diseases, which arise when immune responses are directed against, and damage, the body's own tissues. Collectively their incidence exceeds that of cancer and and they are a leading cause of death and disability, in particular in the Western world.

The Monash Biomedicine Discovery Institute researchers had already shown in studies over the years that decreased levels of PTPN2 result in T-cells attacking the body's own cells and tissues.

In a paper published in the Journal of Experimental Medicine, they drilled deeper, exploring roles for the enzyme in early T-cell development and the development of particular T-cell subsets (αβ and γδ) implicated in the development of different autoimmune and inflammatory diseases.

By removing the gene coding for PTPN2 in laboratory trials, the scientists found that the developmental process for T-cells was skewed towards the generation of γδ T cells with pro-inflammatory properties that are known to contribute to the development of different diseases including Irritable Bowel Disease, Crohn's Disease and rheumatoid arthritis.

"This is an important advance in our understanding of critical checkpoints in T-cell development," lead researcher Professor Tony Tiganis said.

"It helps decide whether the progenitors go on to become T-cells or something else; if they become one type of T-cell or another type," he said.

As part of the study, the researchers looked at the pathways that PTPN2 regulates.

"There are drugs that target some of these pathways – potentially we might be able to use existing drugs to target these pathways in the context of autoimmune and to help a subset of patients with a deficiency in this gene, although that is a long way off," Professor Tiganis said.

First author Dr Florian Wiede said, "Understanding the mechanisms that govern early T-cell development and how these are altered in human disease may ultimately afford opportunities for novel treatments. This is very exciting."

Explore further: New gene mutations found in white blood cells in patients with rheumatoid arthritis

More information: Florian Wiede et al. PTPN2 regulates T cell lineage commitment and αβ versus γδ specification, The Journal of Experimental Medicine (2017). DOI: 10.1084/jem.20161903

Related Stories

New gene mutations found in white blood cells in patients with rheumatoid arthritis

June 21, 2017
Gene mutations accumulating in cells are typical of the development of cancer. Finnish researchers have found that a similar accumulation of mutations occurs also in some patients with rheumatoid arthritis.

Tpl2 enzyme may be target for treating autoimmune diseases

May 22, 2015
New research at the University of Georgia has found that the presence of Tpl2—an enzyme that regulates inflammation—controls the activation of T cells during colitis, an autoimmune disease that occurs when the inner lining ...

Immune cell death safeguards against autoimmune disease

September 6, 2012
Researchers at the Walter and Eliza Hall Institute have discovered that a pair of molecules work together to kill so-called 'self-reactive' immune cells that are programmed to attack the body's own organs. The finding is ...

Preventing too much immunity

December 27, 2016
Scientists at the Immunology Frontier Research Center (IFReC), Osaka University, Japan, report a new molecular mechanism that could explain the cause of some autoimmune diseases.

Trigger for autoimmune disease identified

May 11, 2017
Researchers at National Jewish Health have identified a trigger for autoimmune diseases such as lupus, Crohn's disease and multiple sclerosis. The findings, published in the April 2017 issue of Journal of Clinical Investigation, ...

Battle of the bulge occurs in the liver

June 20, 2014
(Medical Xpress)—An international team of scientists led by Monash University researchers has shown how free radicals contribute to type 2 diabetes, obesity and fatty liver disease.

Recommended for you

Researchers identify source of molecule linked to nasal polyps, asthma attacks

May 23, 2018
A new discovery about how the immune system responds to common sinus infections and asthma could explain why patients develop these issues in the first place and ultimately may lead to improved targeted therapies. Researchers ...

Study demonstrates new treatment for severe asthma

May 22, 2018
Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat ...

Eczema drug effective against severe asthma

May 21, 2018
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies. Dupilumab, an injectable ...

Neuron guidance factor found to play a key role in immune cell function

May 21, 2018
Macrophages are white blood cells involved in a variety of biological functions, from destroying infectious pathogens to repairing damaged tissue. To carry out their different roles, macrophages must first be activated and ...

Immune cells hold promise in slowing down ALS

May 21, 2018
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive ...

First clues to the causes of multiple sclerosis

May 16, 2018
Multiple sclerosis, which affects one in 1,000 people, is frequently characterised by relapses associated with variable functional impairments including among others vision problems, impairment of locomotor functions or difficulties ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.